Barclays’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-47,281
| Closed | -$1.35M | – | 7589 |
|
|
2018
Q4 | $1.35M | Sell |
47,281
-64,909
| -58% | -$1.84M | ﹤0.01% | 2805 |
|
|
2018
Q3 | $3.13M | Buy |
112,190
+31,457
| +39% | +$885K | ﹤0.01% | 2350 |
|
|
2018
Q2 | $2.25M | Buy |
80,733
+13,989
| +21% | +$375K | ﹤0.01% | 2479 |
|
|
2018
Q1 | $1.66M | Sell |
66,744
-25,518
| -28% | -$621K | ﹤0.01% | 2669 |
|
|
2017
Q4 | $2.23M | Sell |
92,262
-304,667
| -77% | -$8.03M | ﹤0.01% | 2329 |
|
|
2017
Q3 | $11M | Buy |
396,929
+395,673
| +31,503% | +$10.6M | 0.01% | 1001 |
|
|
2017
Q2 | $32K | Sell |
1,256
-12,360
| -91% | -$306K | ﹤0.01% | 5585 |
|
|
2017
Q1 | $365K | Buy |
13,616
+7,927
| +139% | +$219K | ﹤0.01% | 3719 |
|
|
2016
Q4 | $149K | Sell |
5,689
-59,124
| -91% | -$1.46M | ﹤0.01% | 4451 |
|
|
2016
Q3 | $1.62M | Buy |
64,813
+64,714
| +65,368% | +$1.51M | ﹤0.01% | 2170 |
|
|
2016
Q2 | $2K | Sell |
99
-4,622
| -98% | -$82.5K | ﹤0.01% | 6019 |
|
|
2016
Q1 | $66K | Sell |
4,721
-9,079
| -66% | -$152K | ﹤0.01% | 4619 |
|
|
2015
Q4 | $290K | Sell |
13,800
-12,938
| -48% | -$241K | ﹤0.01% | 3617 |
|
|
2015
Q3 | $401K | Sell |
26,738
-59,018
| -69% | -$946K | ﹤0.01% | 3549 |
|
|
2015
Q2 | $1.2M | Buy |
85,756
+83,909
| +4,543% | +$1.42M | ﹤0.01% | 2725 |
|
|
2015
Q1 | $31K | Sell |
1,847
-14,151
| -88% | -$250K | ﹤0.01% | 5608 |
|
|
2014
Q4 | $272K | Buy |
15,998
+13,877
| +654% | +$223K | ﹤0.01% | 4391 |
|
|
2014
Q3 | $27K | Sell |
2,121
-3,256
| -61% | -$43.8K | ﹤0.01% | 6307 |
|
|
2014
Q2 | $75K | Sell |
5,377
-15,273
| -74% | -$199K | ﹤0.01% | 5649 |
|
|
2014
Q1 | $248K | Buy |
20,650
+11,603
| +128% | +$151K | ﹤0.01% | 4587 |
|
|
2013
Q4 | $90K | Sell |
9,047
-9,108
| -50% | -$103K | ﹤0.01% | 5730 |
|
|
2013
Q3 | $236K | Buy |
18,155
+15,062
| +487% | +$198K | ﹤0.01% | 4884 |
|
|
2013
Q2 | $44K | Buy |
+3,093
| New | +$38.9K | ﹤0.01% | 6394 |
|
Other funds holding NXTM
Barclays's NXTM Position: Q1 2019 in Review
Barclays sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 47,281 shares — an estimated $1.35M sold.
Barclays first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $11M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Barclays reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 47,281 NxStage Medical Inc. shares in Q1 2019, an estimated $1.35M.
- Barclays first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's NxStage Medical Inc. position peaked at $11M in Q3 2017.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.